Morningstar value Alcidion at 16 cents - Clinical Decision Support Systems | Alcidion

Morningstar value Alcidion at 16 cents

Home / General News / Morningstar value Alcidion at 16 cents
In General News
Morningstar, a trusted and reliable resource for investors, has given Alcidion Group Limited (ASX:ALC) a fair value assessment of $0.16. In their Quantitative Equity Report, released on 30 November 2016, Morningstar assess Alcidion stocks to be undervalued, at the time the report was written the share price was $0.14.

Alcidion is pleased with the assessment, 10 months into our first year as a publicly listed company, we take it as a positive sign that Morningstar has assessed the share price at a fair value of $0.16.

Note: Please be aware this is a quantitative report and therefore a number of the things on the report could change daily – close price, fair value, market cap.

Contact Us

Want some more information? Leave us a message and we will get back to you.